Correlation Between Goff Corp and Medipharm Labs
Can any of the company-specific risk be diversified away by investing in both Goff Corp and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Goff Corp and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Goff Corp and Medipharm Labs Corp, you can compare the effects of market volatilities on Goff Corp and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Goff Corp with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Goff Corp and Medipharm Labs.
Diversification Opportunities for Goff Corp and Medipharm Labs
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Goff and Medipharm is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Goff Corp and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Goff Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Goff Corp are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Goff Corp i.e., Goff Corp and Medipharm Labs go up and down completely randomly.
Pair Corralation between Goff Corp and Medipharm Labs
Given the investment horizon of 90 days Goff Corp is expected to generate 7.55 times more return on investment than Medipharm Labs. However, Goff Corp is 7.55 times more volatile than Medipharm Labs Corp. It trades about 0.11 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about -0.05 per unit of risk. If you would invest 1.34 in Goff Corp on September 25, 2024 and sell it today you would earn a total of 1.06 from holding Goff Corp or generate 79.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Goff Corp vs. Medipharm Labs Corp
Performance |
Timeline |
Goff Corp |
Medipharm Labs Corp |
Goff Corp and Medipharm Labs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Goff Corp and Medipharm Labs
The main advantage of trading using opposite Goff Corp and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Goff Corp position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.Goff Corp vs. Fresnillo PLC | Goff Corp vs. Compania de Minas | Goff Corp vs. Triple Flag Precious | Goff Corp vs. Zimplats Holdings Limited |
Medipharm Labs vs. Genesis Electronics Group | Medipharm Labs vs. Nextmart | Medipharm Labs vs. Emergent Health Corp | Medipharm Labs vs. Goff Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |